Barclays Maintains Overweight on Alvotech, Raises Price Target to $20
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Balaji Prasad has maintained an Overweight rating on Alvotech (NASDAQ:ALVO) and increased the price target from $17 to $20.
March 22, 2024 | 10:42 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays has maintained an Overweight rating on Alvotech and raised the price target from $17 to $20.
The upgrade in price target by a reputable analyst like Balaji Prasad from Barclays indicates a strong confidence in Alvotech's future performance. This is likely to positively influence investor sentiment and potentially increase the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100